Literature DB >> 26134988

Administration of Bifidobacterium breve Decreases the Production of TNF-α in Children with Celiac Disease.

Martina Klemenak1, Jernej Dolinšek2, Tomaž Langerholc3, Diana Di Gioia4, Dušanka Mičetić-Turk5.   

Abstract

BACKGROUND: Increasing evidence suggests that not only genetics, but also environmental factors like gut microbiota dysbiosis play an important role in the pathogenesis of celiac disease (CD). AIM: The aim of our study was to investigate the effect of two probiotic strains Bifidobacterium breve BR03 and B. breve B632 on serum production of anti-inflammatory cytokine interleukin 10 (IL-10) and pro-inflammatory cytokine tumor necrosis factor alpha (TNF-α) in children with CD.
METHODS: The study was a double-blinded, placebo-controlled trial that included 49 children with CD on gluten-free diet (GFD) randomized into two groups and 18 healthy children in the control group. The first group (24 children with CD) daily received B. breve BR03 and B632 (2 × 10(9) colony-forming units) and the second group (25 children with CD) received placebo for 3 months.
RESULTS: TNF-α levels were significantly decreased in the first group after receiving B. breve for 3 months. On follow-up, 3 months after receiving probiotics, TNF-α levels increased again. Children with CD who were on GFD for less than 1 year showed similar baseline TNF-α levels as children who were on GFD for more than 1 year. IL-10 levels were in all groups of patients below detection level.
CONCLUSIONS: Probiotic intervention with B. breve strains has shown a positive effect on decreasing the production of pro-inflammatory cytokine TNF-α in children with CD on GFD.

Entities:  

Keywords:  Bifidobacterium breve; Celiac disease; Children; Cytokines; TNF-α

Mesh:

Substances:

Year:  2015        PMID: 26134988     DOI: 10.1007/s10620-015-3769-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

Review 1.  Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition.

Authors: 
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

Review 2.  Latest developments in the pathogenesis and treatment of celiac disease.

Authors:  David Branski; Alessio Fasano; Riccardo Troncone
Journal:  J Pediatr       Date:  2006-09       Impact factor: 4.406

3.  Persistent duodenal intraepithelial lymphocytosis despite a long-term strict gluten-free diet in celiac disease.

Authors:  Ilus Tuire; Lähdeaho Marja-Leena; Salmi Teea; Haimila Katri; Partanen Jukka; Saavalainen Päivi; Huhtala Heini; Mäki Markku; Collin Pekka; Kaukinen Katri
Journal:  Am J Gastroenterol       Date:  2012-07-24       Impact factor: 10.864

4.  Capability of the two microorganisms Bifidobacterium breve B632 and Bifidobacterium breve BR03 to colonize the intestinal microbiota of children.

Authors:  Luca Mogna; Mario Del Piano; Giovanni Mogna
Journal:  J Clin Gastroenterol       Date:  2014 Nov-Dec       Impact factor: 3.062

Review 5.  The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet.

Authors:  Christopher S McAllister; Martin F Kagnoff
Journal:  Semin Immunopathol       Date:  2012-06-07       Impact factor: 9.623

6.  Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease.

Authors:  M C Collado; E Donat; C Ribes-Koninckx; M Calabuig; Y Sanz
Journal:  J Clin Pathol       Date:  2008-11-07       Impact factor: 3.411

7.  Distinct Bifidobacterium strains drive different immune responses in vitro.

Authors:  Patricia López; Miguel Gueimonde; Abelardo Margolles; Ana Suárez
Journal:  Int J Food Microbiol       Date:  2010-01-04       Impact factor: 5.277

8.  Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa.

Authors:  V M Salvati; G Mazzarella; C Gianfrani; M K Levings; R Stefanile; B De Giulio; G Iaquinto; N Giardullo; S Auricchio; M G Roncarolo; R Troncone
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

9.  Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon.

Authors:  Seong Gyu Jeon; Hisako Kayama; Yoshiyasu Ueda; Takuya Takahashi; Takashi Asahara; Hirokazu Tsuji; Noriko M Tsuji; Hiroshi Kiyono; Ji Su Ma; Takashi Kusu; Ryu Okumura; Hiromitsu Hara; Hiroki Yoshida; Masahiro Yamamoto; Koji Nomoto; Kiyoshi Takeda
Journal:  PLoS Pathog       Date:  2012-05-31       Impact factor: 6.823

10.  Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization.

Authors:  Raffaella Di Cagno; Maria De Angelis; Ilaria De Pasquale; Maurice Ndagijimana; Pamela Vernocchi; Patrizia Ricciuti; Francesca Gagliardi; Luca Laghi; Carmine Crecchio; Maria Elisabetta Guerzoni; Marco Gobbetti; Ruggiero Francavilla
Journal:  BMC Microbiol       Date:  2011-10-04       Impact factor: 3.605

View more
  38 in total

Review 1.  Dysbiosis a risk factor for celiac disease.

Authors:  Anamaria Girbovan; Genel Sur; Gabriel Samasca; Iulia Lupan
Journal:  Med Microbiol Immunol       Date:  2017-02-15       Impact factor: 3.402

2.  Novel Drug Therapeutics in Celiac Disease: A Pipeline Review.

Authors:  Sanskriti Varma; Suneeta Krishnareddy
Journal:  Drugs       Date:  2022-10-17       Impact factor: 11.431

3.  Specific gut microbiome signature predicts the early-stage lung cancer.

Authors:  Yajuan Zheng; Zhaoyuan Fang; Yun Xue; Jian Zhang; Junjie Zhu; Renyuan Gao; Shun Yao; Yi Ye; Shihui Wang; Changdong Lin; Shiyang Chen; Hsinyi Huang; Liang Hu; Ge-Ning Jiang; Huanlong Qin; Peng Zhang; Jianfeng Chen; Hongbin Ji
Journal:  Gut Microbes       Date:  2020-04-02

Review 4.  Current and emerging therapies for coeliac disease.

Authors:  Laura Kivelä; Alberto Caminero; Daniel A Leffler; Maria Ines Pinto-Sanchez; Jason A Tye-Din; Katri Lindfors
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-11-20       Impact factor: 46.802

Review 5.  International Society of Sports Nutrition Position Stand: Probiotics.

Authors:  Ralf Jäger; Alex E Mohr; Katie C Carpenter; Chad M Kerksick; Martin Purpura; Adel Moussa; Jeremy R Townsend; Manfred Lamprecht; Nicholas P West; Katherine Black; Michael Gleeson; David B Pyne; Shawn D Wells; Shawn M Arent; Abbie E Smith-Ryan; Richard B Kreider; Bill I Campbell; Laurent Bannock; Jonathan Scheiman; Craig J Wissent; Marco Pane; Douglas S Kalman; Jamie N Pugh; Jessica A Ter Haar; Jose Antonio
Journal:  J Int Soc Sports Nutr       Date:  2019-12-21       Impact factor: 5.150

Review 6.  Microbiome in Rheumatoid Arthritis and Celiac Disease: A Friend or Foe.

Authors:  Kawther Elsouri; Vania Arboleda; Samantha Heiser; Marc M Kesselman; Michelle Demory Beckler
Journal:  Cureus       Date:  2021-06-09

Review 7.  Intestinal Microbiota and Celiac Disease: Cause, Consequence or Co-Evolution?

Authors:  María Carmen Cenit; Marta Olivares; Pilar Codoñer-Franch; Yolanda Sanz
Journal:  Nutrients       Date:  2015-08-17       Impact factor: 5.717

8.  Probiotic Bacillus coagulans GBI-30, 6086 reduces exercise-induced muscle damage and increases recovery.

Authors:  Ralf Jäger; Kevin A Shields; Ryan P Lowery; Eduardo O De Souza; Jeremy M Partl; Chase Hollmer; Martin Purpura; Jacob M Wilson
Journal:  PeerJ       Date:  2016-07-21       Impact factor: 2.984

9.  Probiotic Streptococcus thermophilus FP4 and Bifidobacterium breve BR03 Supplementation Attenuates Performance and Range-of-Motion Decrements Following Muscle Damaging Exercise.

Authors:  Ralf Jäger; Martin Purpura; Jason D Stone; Stephanie M Turner; Anthony J Anzalone; Micah J Eimerbrink; Marco Pane; Angela Amoruso; David S Rowlands; Jonathan M Oliver
Journal:  Nutrients       Date:  2016-10-14       Impact factor: 5.717

Review 10.  Gut microbiota in Celiac Disease: microbes, metabolites, pathways and therapeutics.

Authors:  Katherine L Olshan; Maureen M Leonard; Gloria Serena; Ali R Zomorrodi; Alessio Fasano
Journal:  Expert Rev Clin Immunol       Date:  2020-12-27       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.